Atrial fibrillation in cancer survivors - a systematic review and meta-analysis.

ABSTRACT:

Background

Atrial fibrillation (AF) is a common cardiac complication during cancer treatment. It is unclear if cancer survivors have increased AF risk when compared to the population. AF screening is now recommended in patients ≥65 years, however there are no specific recommendations in the oncology population. We sought to compare the AF detection rate of cancer survivors compared to the general population.

Methods

We searched the Pubmed, Embase and Web of Science databases using search terms related to AF and cancer mapped to subject headings. We included English language studies, limited to adults > 18 years who were > 12 months post completion of cancer treatment. Using a random-effects model we calculated the overall AF detection rate. Meta-regression analysis was perfo

SUBMITTER: Bao Y 

PROVIDER: S-EPMC10276447 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature